FDA panel votes to keep severe warning on Pfizer anti-smoking drug

(Reuters) - Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.

Source: Reuters: Health - October 16, 2014 Category: Consumer Health News Tags: healthNews Source Type: news